Pfizer Covid-19-vaccination multiplies by 15 mortality among fully vaccinated COVID-19 patients, putatively by weakening the immune system
Hervé Seligmann and Haim Yativ
15. Mar. 2021
A German journalist, Alice Echtermann published data cumulated from December 20 to March 10, according to her from the Israel Ministry of Health, on vaccinated and unvaccinated COVID-19 patients,
Her interpretation of these data, reacting to a nakim.org publication, is that vaccination decreased deaths, from 1566 (unvaccinated) to 709 (between doses), to 84 (within 7 days after 2nd dose), and to 105 (7 days after 2nd dose) (Table 1). This is misleading because vaccination statuses differ in durations and sample sizes. Adjusted for time, there are 20 (=1566/80), 34, 12 and 4 deaths/day for the different vaccination statuses, in the same order as above. Adjusted for total COVID-19 patient numbers, deaths/day per person increase from unvaccinated to fully vaccinated (Table 1) and are greater by 11.65, 27.92, and 15 (390-7.49) than for the unvaccinated (Table 1). This confirms a threefold increase in COVID-19 detection rates during the first 7 days after the 1st dose, as compared to initial COVID-19 rates on 1st dose injection day.
We also see that percentages of asymptomatic cases (community) decrease from unvaccinated to fully vaccinated. Vaccination probably weakens natural immune reactions, increases risks precisely for those vaccination should protect.
We stress that
1. this does not include non-COVID-19 adverse reactions resulting from vaccination-induced immune system weakening,
2. our straightforward analyses are as true as reported data, and
3. results don’t contradict the possibility that full vaccination decreases COVID-19 incidences.
Point 3 requires information unreported in the original table, namely numbers of individuals without COVID-19 for each vaccination status.
Notably, unlike other countries, the Israeli Health Ministry, does not recommend outpatient care with potentially helpful medicines as zinc, ivermectin, or vitamins C and D.
Massive vaccination should be reconsidered and all non-COVID-19 adverse reactions examined in relation to vaccination status.
the original table:
you can download this article below in pdf